Beginning Dec. 1, 2025, we’ll require notification/prior authorization for the following specialty medications for UnitedHealthcare Community Plan in North Carolina:
| Medication | HCPCS code(s) | 
|---|---|
| Casgevy® (exagamglogene autotemcel) | J3392 | 
| Elevidys™ (delandistrogene moxeparvovec-rokl) | J1413 | 
| Hemgenix™ (etranacogene dezaparvovec-drlb) | J1411 | 
| Lenmeldy™ (atidarsagene autotemcel) | J3391 | 
| Luxturna® (voretigene neparvovec-rzyl) | J3398 | 
| Lyfgenia™ (lovotibeglogene autotemcel) | J3394 | 
| Roctavian™ (valoctogcogene roxaparvovec-rvox) | J1412 | 
| Skysona® (elivaldogene autotemcel) | J3490, J3590, C9399 | 
| Zolgensma® (onasemnogene abeparvovec-xioi) | J3399 | 
| Zynteglo™ (betibeglogene autotemcel) | J3393 | 
For training, view our Prior Authorization and Notification interactive guide.
Please note: For the following cell and gene therapies, you must contact Optum Transplant Services at 888-805-1802 to submit your prior authorization request:
Prior authorization requests must be received before the date of service. If a request is not received in advance, providers are not permitted to balance bill the member if their claim is denied.
Connect with us through chat 24/7 in the UnitedHealthcare Provider Portal.
PCA-1-25-01540-M&R-NN_08062025